Youngy Health Statistics
Total Valuation
Youngy Health has a market cap or net worth of CNY 3.46 billion. The enterprise value is 3.05 billion.
| Market Cap | 3.46B |
| Enterprise Value | 3.05B |
Important Dates
The last earnings date was Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Youngy Health has 804.04 million shares outstanding. The number of shares has increased by 6.40% in one year.
| Current Share Class | 804.04M |
| Shares Outstanding | 804.04M |
| Shares Change (YoY) | +6.40% |
| Shares Change (QoQ) | -11.70% |
| Owned by Insiders (%) | 3.15% |
| Owned by Institutions (%) | 2.37% |
| Float | 621.81M |
Valuation Ratios
The trailing PE ratio is 52.90.
| PE Ratio | 52.90 |
| Forward PE | n/a |
| PS Ratio | 3.75 |
| PB Ratio | 2.71 |
| P/TBV Ratio | 3.09 |
| P/FCF Ratio | 51.40 |
| P/OCF Ratio | 42.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.61, with an EV/FCF ratio of 45.33.
| EV / Earnings | 45.14 |
| EV / Sales | 3.31 |
| EV / EBITDA | 19.61 |
| EV / EBIT | 21.66 |
| EV / FCF | 45.33 |
Financial Position
The company has a current ratio of 8.02, with a Debt / Equity ratio of 0.06.
| Current Ratio | 8.02 |
| Quick Ratio | 4.92 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 1.17 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.25% and return on invested capital (ROIC) is 13.59%.
| Return on Equity (ROE) | 8.25% |
| Return on Assets (ROA) | 6.20% |
| Return on Invested Capital (ROIC) | 13.59% |
| Return on Capital Employed (ROCE) | 10.25% |
| Weighted Average Cost of Capital (WACC) | 6.65% |
| Revenue Per Employee | 1.90M |
| Profits Per Employee | 139,575 |
| Employee Count | 484 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 3.25 |
Taxes
In the past 12 months, Youngy Health has paid 39.59 million in taxes.
| Income Tax | 39.59M |
| Effective Tax Rate | 28.05% |
Stock Price Statistics
The stock price has increased by +20.45% in the last 52 weeks. The beta is 0.46, so Youngy Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +20.45% |
| 50-Day Moving Average | 4.70 |
| 200-Day Moving Average | 4.67 |
| Relative Strength Index (RSI) | 37.12 |
| Average Volume (20 Days) | 13,456,023 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Youngy Health had revenue of CNY 921.41 million and earned 67.55 million in profits. Earnings per share was 0.08.
| Revenue | 921.41M |
| Gross Profit | 337.25M |
| Operating Income | 140.75M |
| Pretax Income | 141.12M |
| Net Income | 67.55M |
| EBITDA | 154.23M |
| EBIT | 140.75M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 607.83 million in cash and 78.71 million in debt, giving a net cash position of 529.12 million or 0.66 per share.
| Cash & Cash Equivalents | 607.83M |
| Total Debt | 78.71M |
| Net Cash | 529.12M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 1.28B |
| Book Value Per Share | 1.44 |
| Working Capital | 950.87M |
Cash Flow
In the last 12 months, operating cash flow was 81.59 million and capital expenditures -14.33 million, giving a free cash flow of 67.26 million.
| Operating Cash Flow | 81.59M |
| Capital Expenditures | -14.33M |
| Depreciation & Amortization | 13.49M |
| Net Borrowing | n/a |
| Free Cash Flow | 67.26M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 36.60%, with operating and profit margins of 15.28% and 7.33%.
| Gross Margin | 36.60% |
| Operating Margin | 15.28% |
| Pretax Margin | 15.32% |
| Profit Margin | 7.33% |
| EBITDA Margin | 16.74% |
| EBIT Margin | 15.28% |
| FCF Margin | 7.30% |
Dividends & Yields
Youngy Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.40% |
| Shareholder Yield | -6.40% |
| Earnings Yield | 1.95% |
| FCF Yield | 1.95% |
Stock Splits
The last stock split was on April 29, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Apr 29, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |